Zobrazeno 1 - 10
of 11
pro vyhledávání: '"David Sergeenko"'
Autor:
Josephine G Walker, PhD, Tinatin Kuchuloria, MD, David Sergeenko, MD, Hannah Fraser, PhD, Aaron G Lim, DPhil, Shaun Shadaker, MPH, Liesl Hagan, MPH, Amiran Gamkrelidze, ProfPhD, Valeri Kvaratskhelia, MD, Lia Gvinjilia, MD, Malvina Aladashvili, MD, Alexander Asatiani, MD, Davit Baliashvili, MD, Maia Butsashvili, ProfPhD, Ivdity Chikovani, MD, Irma Khonelidze, MD, Irma Kirtadze, PhD, Mark H Kuniholm, PhD, David Otiashvili, PhD, Lali Sharvadze, PhD, Ketevan Stvilia, MD, Tengiz Tsertsvadze, ProfPhD, Mamuka Zakalashvili, MD, Matthew Hickman, PhD, Natasha K Martin, DPhil, Juliette Morgan, MD, Muazzam Nasrullah, PhD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publikováno v:
The Lancet Global Health, Vol 8, Iss 2, Pp e244-e253 (2020)
Summary: Background: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up tr
Externí odkaz:
https://doaj.org/article/3bc3fb73a00649c1884f1f75f9adb138
Autor:
Ekaterine Adamia, Stefan Zeuzem, Francisco Averhoff, Sanjeev Arora, Lia Gvinjilia, Akaki Abutidze, Amiran Gamkrelidze, Nezam H. Afdhal, Muazzam Nasrullah, Beth Skaggs, Karla Thornton, David Metreveli, Nikoloz Chkhartishvili, Maia Butsashvili, Vakhtang Kerashvili, Tengiz Tsertsvadze, Shaun Shadaker, Maia Lagvilava, Lali Sharvadze, Tinatin Kuchuloria, David Sergeenko
Publikováno v:
Clin Infect Dis
Background In April 2015, in collaboration with the US Centers for Disease Control and Prevention and Gilead Sciences, the country of Georgia embarked on the world’s first hepatitis C elimination program. We aimed to assess progress toward eliminat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57bce3b866237363f62293211019e175
https://doi.org/10.1093/cid/ciz956
https://doi.org/10.1093/cid/ciz956
Autor:
Lia Gvinjilia, Akaki Abutidze, Muazzam Nasrullah, David Metreveli, Amiran Gamkrelidze, David Sergeenko, F. Averhoff, Maia Butsashvili, Nikoloz Chkhartishvili, Tengiz Tsertsvadze
Publikováno v:
Hepatitis C: Epidemiology, Prevention and Elimination ISBN: 9783030646486
Georgia is a small Eastern European country (population: 3.7 million people) situated in the Caucasus between Russia and Turkey. The country has the fifth highest prevalence of hepatitis C in the world with an estimated 5.4% of adult population (150,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99510796029014c98cf853a646e04c1d
https://doi.org/10.1007/978-3-030-64649-3_13
https://doi.org/10.1007/978-3-030-64649-3_13
Autor:
Lia Gvinjilia, Maia Alkhazashvili, Lali Sharvadze, Muazzam Nasrullah, David Metreveli, Shaun Shadaker, Amiran Gamkrelidze, Tengiz Tsertsvadze, David Sergeenko, Maia Butsashvili, John W. Ward, Juliette Morgan, Francisco Averhoff
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report
Georgia, a country in the Caucasus region of Eurasia, has a high prevalence of hepatitis C virus (HCV) infection. In April 2015, with technical assistance from CDC, Georgia embarked on the world's first program to eliminate hepatitis C, defined as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309d02b6e18dc5b7a3454316257f6fcc
https://doi.org/10.15585/mmwr.mm6629a2
https://doi.org/10.15585/mmwr.mm6629a2
Autor:
Amiran Gamkrelidze, Vladimer Getia, David Sergeenko, Tengiz Tsertsvadze, Maia Butsashvili, Jaba Zarkua, Muazzam Nasrullah, Shaun Shadaker, Lia Gvinjilia, Tatia Kuchuloria, Beth Skaggs, Lali Sharvadze, Francisco Averhoff
Publikováno v:
J Hepatol
Background & Aims Georgia, with a high prevalence of HCV infection, launched the world's first national hepatitis C elimination program in April 2015. A key strategy is the identification, treatment, and cure of the estimated 150,000 HCV-infected peo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb264110cb28208c922c293742875c20
https://pubmed.ncbi.nlm.nih.gov/31811882
https://pubmed.ncbi.nlm.nih.gov/31811882
Autor:
Lali Sharvadze, Lia Gvinjilia, Irinka Tskhomelidze, Maka Gogia, Maia Japaridze, Jaba Zarkua, Maia Butsashvili, Amiran Gamkrelidze, Tinatin Kuchuloria, Khatuna Kutateladze, Shaun Shadaker, Philip R. Spradling, Muazzam Nasrullah, Irma Khonelidze, Francisco Averhoff, Tengiz Tsertsvadze, Alexander Asatiani, Ketevan Stvilia, David Sergeenko
Publikováno v:
Morbidity and Mortality Weekly Report
In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world's first national elimination program (1,2). Nearly 40% of these in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b3529a68884455171b949912978090
https://pubmed.ncbi.nlm.nih.gov/31344021
https://pubmed.ncbi.nlm.nih.gov/31344021
Autor:
Lia Gvinjilia, Muazzam Nasrullah, Liesl Hagan, Amiran Gamkrelidze, V. Kvaratskhelia, Malvina Aladashvili, David Sergeenko, Peter Vickerman, Tengiz Tsertsvadze, Natasha K. Martin, D. Baliashvili, Ivdity Chikovani, Maia Butsashvili, Irma Kirtadze, Josephine G. Walker, Ketevan Stvilia, Lali Sharvadze, Francisco Averhoff, Tinatin Kuchuloria, Alexander Asatiani, Aaron G Lim, Mamuka Zakalashvili, Juliette Morgan, Hannah Fraser, David Otiashvili, Matthew Hickman, Shaun Shadaker, Mark H. Kuniholm, Irma Khonelidze
Publikováno v:
The Lancet Global Health, Vol 8, Iss 2, Pp e244-e253 (2020)
Walker, J G, Fraser, H, Lim, A G, Hickman, M, Martin, N, Vickerman, P & al., E 2020, ' Interim impact evaluation of the hepatitis C elimination program in Georgia : a modelling study ', Lancet Global Health, vol. 8, no. 2, pp. PE244-E253 . https://doi.org/10.1016/S2214-109X(19)30483-8
The Lancet. Global Health
Walker, J G, Fraser, H, Lim, A G, Hickman, M, Martin, N, Vickerman, P & al., E 2020, ' Interim impact evaluation of the hepatitis C elimination program in Georgia : a modelling study ', Lancet Global Health, vol. 8, no. 2, pp. PE244-E253 . https://doi.org/10.1016/S2214-109X(19)30483-8
The Lancet. Global Health
Summary Background Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a84ff961a43b792277d84442f340226
https://pubmed.ncbi.nlm.nih.gov/31864918
https://pubmed.ncbi.nlm.nih.gov/31864918
Autor:
Margaret Hellard, Amiran Gamkrelidze, Lali Sharvadze, Tamar Gabunia, Francisco Averhoff, Massimo Colombo, Stefano Gnes, David Metreveli, David Sergeenko, Tengiz Tsertsvadze, Jeffrey V. Lazarus, Maia Butsashvili, Muazzam Nasrullah
Publikováno v:
Journal of hepatology. 71(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b29f8ae604c2cf0d591b4a4eba4a465b
https://pubmed.ncbi.nlm.nih.gov/31356831
https://pubmed.ncbi.nlm.nih.gov/31356831
Autor:
Maia Tsereteli, Amiran Gamkrelidze, Vladimer Getia, D. Baliashvili, Maia Lagvilava, Ekaterine Adamia, A. Aslanikashvili, Alexander Turdziladze, Maia Alkhazashvili, Irma Khonelidze, David Sergeenko, Paata Imnadze
Publikováno v:
Journal of Hepatology. 70:e329-e330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb619670287ad115fa14009c9dc6a0f0
https://doi.org/10.1016/s0618-8278(19)30644-9
https://doi.org/10.1016/s0618-8278(19)30644-9
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 14:447-448
In April 2015, in partnership with the US Centers for Disease Control and Prevention and Gilead Sciences, the country of Georgia launched the world's first national HCV elimination programme, aiming to reduce HCV prevalence by 90% by 2020. After 2 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd06880136a07861f38bb129d9f49dfe
https://doi.org/10.1038/nrgastro.2017.100
https://doi.org/10.1038/nrgastro.2017.100